These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 6815138)

  • 21. Radiobiology with heavy charged particles: a historical review.
    Skarsgard LD
    Phys Med; 1998 Jul; 14 Suppl 1():1-19. PubMed ID: 11542635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current status of clinical pion radiotherapy.
    Kligerman MM; Black WC; Yuhas JM; Doberneck RC; Bradbury JN; Kelsey CA
    Radiology; 1977 Nov; 125(2):489-92. PubMed ID: 910063
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Initial performance of the Stanford Medical pion generator.
    Pistenma DA; Fessenden P; Boyd DP; Luxton G; Taber R; Bagshaw MA
    Radiology; 1977 Feb; 122(2):527-9. PubMed ID: 834908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The response of mouse epidermis to fractionated doses of pi mesons.
    Chaplin DJ; Douglas BG; Grulkey W; Skarsgard LD; Lam G; Denekamp J
    Int J Radiat Oncol Biol Phys; 1987 Aug; 13(8):1199-208. PubMed ID: 3610708
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preclinical radiobiology with pions: RBE--values for mouse skin damage as a function of single doses of pions.
    Fröhlich EM; Blattmann H; Pfister L; Cordt I; Zehnder J; Fritz-Niggli H
    Radiat Environ Biophys; 1979 Aug; 16(3):289-94. PubMed ID: 504560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Muon dose distribution from a decaying pencil beam of pions.
    Brosing JW; Henkelman RM
    Phys Med Biol; 1981 Jul; 26(4):633-40. PubMed ID: 6789343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiobiology of pions in comparison with other heavy particles.
    Raju MR; van der Kogel AJ
    Radiother Oncol; 1990 Jan; 17(1):1-5. PubMed ID: 2108472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. On the use of the pion stopping distribution and the lesion additivity concept for the calculation of effective doses in pion treatment planning.
    Lam GK
    Phys Med Biol; 1990 Jun; 35(6):731-40. PubMed ID: 2114647
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The relative biological effectiveness of antiprotons.
    Holzscheiter MH; Alsner J; Bassler N; Boll R; Caccia M; Knudsen H; Maggiore C; Petersen JB; Sellner S; Straße T; Singers Sørensen B; Overgaard J
    Radiother Oncol; 2016 Dec; 121(3):453-458. PubMed ID: 27988058
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preparatory clinical studies of Pi-mesons at TRIUMF.
    Goodman GB; Dixon P; Lam GK; Harrison R; Kornelsen RO; Ludgate CM; Flores AD
    Radiat Res Suppl; 1985; 8():S279-84. PubMed ID: 3003786
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapy planning and dosimetry for the pion applicator at the Swiss Institute for Nuclear Research (SIN).
    Blattmann H
    Radiat Environ Biophys; 1979 Aug; 16(3):205-9. PubMed ID: 116304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measurement of the effect of inhomogeneities and compensating bolus in clinical pion beams.
    Hogstrom KR; Smith AR; Somers JW; Lane RG; Rosen II; Simon SL; Kelsey CA
    Med Phys; 1979; 6(1):26-31. PubMed ID: 440228
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiproton radiotherapy.
    Bassler N; Alsner J; Beyer G; DeMarco JJ; Doser M; Hajdukovic D; Hartley O; Iwamoto KS; Jäkel O; Knudsen HV; Kovacevic S; Møller SP; Overgaard J; Petersen JB; Solberg TD; Sørensen BS; Vranjes S; Wouters BG; Holzscheiter MH
    Radiother Oncol; 2008 Jan; 86(1):14-9. PubMed ID: 18158194
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pion therapy at TRIUMF. Treatment results for astrocytoma grades 3 and 4: a pilot study.
    Goodman GB; Skarsgard LD; Thompson GB; Harrison R; Lam GK; Lugate C
    Radiother Oncol; 1990 Jan; 17(1):21-8. PubMed ID: 2157239
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spot scanning for 250 MeV protons.
    Blattmann H; Coray A; Pedroni E; Greiner R
    Strahlenther Onkol; 1990 Jan; 166(1):45-8. PubMed ID: 2154048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of a dynamic rangeshifter for modifying the depth-dose distributions of negative pions.
    Amols HI; Liska DJ; Halbig J
    Med Phys; 1977; 4(5):404-7. PubMed ID: 409920
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Measurements at the piE3 single beam correlated to dosimetry and therapy-planning for the pion applicator at SIN.
    Salzmann M
    Radiat Environ Biophys; 1979 Aug; 16(3):219-23. PubMed ID: 116306
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-LET pion dose contours under the LAMPF biomedical channel by plastic track detector scanning.
    Knowles HB; Ruddy FH; West GW; Kligerman MM
    Med Phys; 1979; 6(1):32-8. PubMed ID: 440229
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The applicability of pions to cancer radiotherapy. I. Experimental measurements of the capture and absorption of pions in polymer].
    Maki T; Nakano M; Cho T; Yoshimura A; Yoshinaga H; Uehara S; Hoshi M; Nagoshi C; Onizuka Y; Konishi K
    J UOEH; 1983 Jun; 5(2):221-33. PubMed ID: 6679631
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The suitability of negative pions for radiotherapy: 4 years preclinical research with the biomedical PiE3-beam at SIN.
    Fritz-Niggli H
    Radiat Environ Biophys; 1979 Aug; 16(3):185-92. PubMed ID: 116302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.